This is stated by an investigation whose results would open new routes for the treatment of reproductive variations linked to this disease.
The researcher at Vigo Vigo Verónica Outeiriño has demonstrated in her doctoral thesis that the GLP-1 hormone presents "a stimulating effect" on the reproductive axis of adult females, acts as "puberty activator" and, together with itsLiraglutida analogue, is capable of "restoring much" of the reproductive alterations associated with diabetes.
This has been communicated by the University, which has indicated that the results of this research, directed by doctors Eva María Vigo and Federico Mallo, "open new ways for the treatment of reproductive alterations associated with this disease."
Specifically, this research shows for the first time that prolonged treatment with liraglutide "is able to activate the gonadal axis" although it is not able to achieve its "normal" operation in the case of the Zucker rat, in which the analyzes were donefor presenting, in addition to obesity, irregular cycles and productive difficulties.
"the key"
The researcher explained that "the key" is that the LPG-1, a hormone producedOther pathologies such as low fertility problems, childish delay, etc. "
Likewise, he has pointed to the possibility that these molecules are directly responsible for the improvements detected in women with polycystic ovary -frequent something in diabetic and obese women -as well as beneficial effects on insulin and glycemia levels.
